INVEX THERAPEUTICS LTD - LONDON
Company Profile | Company Filings |
Overview
INVEX THERAPEUTICS LTD is a Private Limited Company from LONDON ENGLAND and has the status: Active.
INVEX THERAPEUTICS LTD was incorporated 4 years ago on 12/12/2019 and has the registered number: 12361382. The accounts status is SMALL and accounts are next due on 31/03/2025.
INVEX THERAPEUTICS LTD was incorporated 4 years ago on 12/12/2019 and has the registered number: 12361382. The accounts status is SMALL and accounts are next due on 31/03/2025.
INVEX THERAPEUTICS LTD - LONDON
This company is listed in the following categories:
72110 - Research and experimental development on biotechnology
72110 - Research and experimental development on biotechnology
Accounts Status
Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
---|---|---|
30 / 6 | 30/06/2023 | 31/03/2025 |
Registered Office
ECCLESTON YARDS
LONDON
SW1W 9NF
ENGLAND
This Company Originates in : United Kingdom
Confirmation Statements
Last Statement | Next Statement Due |
---|---|
11/12/2023 | 25/12/2024 |
Map
ENGLAND
Company Officers - Current and Previous
Name | Born | Nationality | Role | Appointed | Status |
---|---|---|---|---|---|
MR ANTHONY NEVILLE CHISHOLM EASTMAN | Nov 1974 | Australian | Director | 2023-07-10 | CURRENT |
OAKWOOD CORPORATE SECRETARY LIMITED | Corporate Secretary | 2019-12-12 | CURRENT | ||
JASON ANDREW LOVERIDGE | Mar 1961 | Australian | Director | 2019-12-12 UNTIL 2023-07-10 | RESIGNED |
Free Reports Available
Report | Date Filed | Date of Report | Assets |
---|---|---|---|
Invex Therapeutics Ltd - Accounts to registrar (filleted) - small 23.2.5 | 2023-10-06 | 30-06-2023 | £62,276 Cash £-4,526,448 equity |
Invex Therapeutics Ltd - Accounts to registrar (filleted) - small 18.2 | 2022-09-15 | 30-06-2022 | £91,018 Cash £-1,356,551 equity |
Invex Therapeutics Ltd - Accounts to registrar (filleted) - small 18.2 | 2021-11-25 | 30-06-2021 | £27,055 Cash £-353,467 equity |
Invex Therapeutics Ltd - Accounts to registrar (filleted) - small 18.2 | 2020-11-20 | 30-06-2020 | £2,898 Cash £-70,923 equity |